Preoperative aspirin use and acute kidney injury after cardiac surgery: A propensity-score matched observational studyReport as inadecuate

Preoperative aspirin use and acute kidney injury after cardiac surgery: A propensity-score matched observational study - Download this document for free, or read online. Document in PDF available to download.


The association between preoperative aspirin use and postoperative acute kidney injury AKI in cardiovascular surgery is unclear. We sought to evaluate the effect of preoperative aspirin use on postoperative AKI in cardiac surgery.


A total of 770 patients who underwent cardiovascular surgery under cardiopulmonary bypass were reviewed. Perioperative clinical parameters including preoperative aspirin administration were retrieved. We matched 108 patients who took preoperative aspirin continuously with patients who stopped aspirin more than 7 days or did not take aspirin for the month before surgery. The parameters used in the matching included variables related to surgery type, patient’s demographics, underlying medical conditions and preoperative medications.


In the first seven postoperative days, 399 patients 51.8% developed AKI, as defined by the Kidney Disease Improving Global Outcomes KDIGO criteria and 128 patients 16.6% required hemodialysis. Most patients took aspirin 100 mg once daily n = 195, 96.5% and the remaining 75 mg once daily. Multivariable analysis showed that preoperative maintenance of aspirin was independently associated with decreased incidence of postoperative AKI odds ratio OR 0.46, 95% confidence interval CI 0.21–0.98, P = 0.048; after propensity score matching: OR 0.39, 95% CI 0.22–0.67, P = 0.001. Preoperative maintenance of aspirin was associated with less incidence of AKI defined by KDIGO both in the entire and matched cohort n = 44 40.7% vs. 69 63.9% in aspirin and non-aspirin group, respectively in matched sample, relative risk RR 0.64, 95% CI 0.49, 0.83, P = 0.001. Preoperative aspirin was associated with decreased postoperative hospital stay after matching 12 9–18 days vs. 16 10–25 in aspirin and non-aspirin group, respectively, P = 0.038. Intraoperative estimated or calculated blood loss using hematocrit difference and estimated total blood volume showed no difference according to aspirin administration in both entire and matched cohort.


Preoperative low dose aspirin administration without discontinuation was protective against postoperative AKI defined by KDIGO criteria independently in both entire and matched cohort. Preoperative aspirin was also associated with decreased hemodialysis requirements and decreased postoperative hospital stay without increasing bleeding. However, differences in AKI and hospital stay were not associated with in-hospital mortality.

Author: Min Hur , Chang-Hoon Koo , Hyung-Chul Lee, Sun-Kyung Park, Minkyung Kim, Won Ho Kim , Jin-Tae Kim, Jae-Hyon Bahk



Related documents